TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 122 filers reported holding TURNING POINT THERAPEUTICS I in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,583,000 | -41.1% | 58,967 | +3.3% | 0.00% | -50.0% |
| Q4 2021 | $2,688,000 | -28.2% | 57,072 | -1.4% | 0.00% | -33.3% |
| Q3 2021 | $3,742,000 | -14.3% | 57,867 | +3.2% | 0.00% | -25.0% |
| Q2 2021 | $4,368,000 | +15.8% | 56,067 | +40.5% | 0.00% | 0.0% |
| Q1 2021 | $3,773,000 | +54.8% | 39,896 | +99.5% | 0.00% | +33.3% |
| Q4 2020 | $2,437,000 | +108.5% | 20,000 | -35.7% | 0.00% | +200.0% |
| Q3 2019 | $1,169,000 | -46.9% | 31,098 | -42.5% | 0.00% | -66.7% |
| Q2 2019 | $2,201,000 | – | 54,070 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,750,000 | $260,122,000 | 5.80% |
| Burrage Capital Management LLC | 72,164 | $6,826,000 | 5.53% |
| Consonance Capital Management LP | 450,396 | $42,603,000 | 4.54% |
| MPM BioImpact LLC | 269,186 | $25,462,000 | 3.20% |
| Orbimed Advisors | 2,361,327 | $223,358,000 | 2.09% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 81,541 | $7,711,000 | 2.04% |
| SECTORAL ASSET MANAGEMENT INC | 257,879 | $24,393,000 | 1.85% |
| Nicholas Investment Partners, LP | 218,847 | $20,701,000 | 1.44% |
| Logos Global Management LP | 140,000 | $13,243,000 | 1.29% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 16,741 | $1,584,000 | 0.86% |